Anti-inflammatory treatment after discharge home from the emergency department in adults with acute asthma - 12/08/11
Doi : 10.1016/j.jaci.2009.05.007
Jerry A. Krishnan, MD, PhD a, ⁎ 
, Richard Nowak, MD, MBA b, Steven Q. Davis, MD c, Michael Schatz, MD, MS d
, Richard Nowak, MD, MBA b, Steven Q. Davis, MD c, Michael Schatz, MD, MS d a Asthma and COPD Center, Department of Medicine, and Department of Health Studies, University of Chicago, Chicago, Ill
b Department of Emergency Medicine, Henry Ford Health System, Detroit, Mich
c Texas Pulmonary & Critical Care Consultants, PA, Fort Worth, Tex
d Department of Allergy, Kaiser Permanente Medical Center, San Diego, Calif
Reprint requests: Jerry A. Krishnan, MD, PhD, Associate Professor of Medicine and Epidemiology, Director, Asthma and COPD Center, Section of Pulmonary & Critical Care Medicine, University of Chicago, 5841 S. Maryland Ave, MC 6076, Room M644, Chicago, IL 60637.Key words : Asthma exacerbation, acute asthma, emergency department, discharge medications, corticosteroids, leukotriene modifiers
Abbreviations used : ED, ICS, IMCS, OCS, RCT
Plan
| Disclosure of potential conflict of interest: J. A. Krishnan has declared that he has no conflict of interest. R. Nowak has declared that he has no conflict of interest. S. Q. Davis has declared that he has no conflict of interest. M. Schatz has been a consultant for GlaxoSmithKline and has received research support from Aerocrine, Genentech, GlaxoSmithKline and Merck. |
|
| This article is part of the Joint Task Force Report: Supplemental Recommendations for the Management and Follow-up of Asthma Exacerbations, an official statement of the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American Academy of Emergency Medicine (AAEM), and the American Thoracic Society (ATS). It was approved by the AAAAI Board of Directors, January 16, 2008, the AAEM Board of Directors, January 14, 2008, and the ATS Board of Directors, March 13, 2009. |
|
| The Joint Task Force Report is copublished in the Journal of Allergy and Clinical Immunology, the Journal of Emergency Medicine, and the Proceedings of the American Thoracic Society. |
© 2009
American Academy of Allergy, Asthma & Immunology, American Thoracic Society, and Elsevier Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 124 - N° 2S
P. S29-S34 - août 2009 Retour au numéro
Article précédent
- Intubation and mechanical ventilation of the asthmatic patient in respiratory failure
- Barry Brenner, Thomas Corbridge, Antoine Kazzi
- Follow-up after acute asthma episodes: What improves future outcomes?
- Michael Schatz, Gary Rachelefsky, Jerry A. Krishnan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?